Real-World test: finding the best treatment for frail myeloma patients

This study compares two standard drug combinations, with or without an additional medication called daratumumab, for older adults with multiple myeloma who cannot receive a stem cell transplant. It aims to find which treatment works best in everyday clinical practice, focusing on controlling the cancer, managing side effects, and maintaining quality of life. The research specifically looks at how a patient's overall health and frailty affect their treatment outcomes.